Prabhav Aggarwal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Prabhav Aggarwal has a total of 79 co-authors. Here are the top co-authors by number of shared publications:
- Sonal Saxena
Department of Microbiology, Maulana Azad Medical College, New Delhi, India
5 shared publications Beena Uppal
Department of Microbiology, Maulana Azad Medical College, Bahadur Shah Zafar Road, New Delhi-110002, India
4 shared publicationsKrishnan Rajeshwari
Department of Pediatrics, Maulana Azad Medical College and associated Lok Nayak Hospital, Bahadur Shah Zafar Road, New Delhi-110002, India
3 shared publicationsRoumi Ghosh
Department of Microbiology, Maulana Azad Medical College, Bahadur Shah Zafar Road, New Delhi-110002, India
3 shared publicationsSonal Saxena
Department of Microbiology, Maulana Azad Medical College, New Delhi, India
3 shared publicationsAnita Chakravarti
Department of Microbiology, Maulana Azad Medical College, Bahadur Shah Zafar Road, New Delhi-110002, India
2 shared publications
Latest Publications
- Open Access
- 30 March 2026
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 8 (2) , 139-143
Modification of CLSI Recommended Colistin Agar Test for Enterobacterales to Handle Large Sample Load in a High-Throughput Laboratory
Objective: Accurate colistin susceptibility testing is critical but remains challenging, especially in resource-limited settings with a high workload. Broth microdilution (BMD) is the reference standard; however, it is time- and resource-intensive. The colistin agar test (CAT) offers a viable alternative; however, the additional step of preparing a 1:10 dilution can limit routine workflow. This study aimed to evaluate a simple modification of the CAT for Enterobacterales. Materials and Methods: Enterobacterales isolates were tested using BMD, the standard CAT, and modified CAT (mCAT). The mCAT uses an undiluted 0.5 McFarland inoculum with a reduced inoculum volume (1 µL), instead of the Clinical and Laboratory Standards Institute (CLSI)-recommended 10 µL of a one-tenth-diluted suspension, simplifying the protocol while maintaining an equivalent bacterial inoculum load. Results: A total of 306 Enterobacterales isolates (102 colistin-resistant and 204 intermediate) were evaluated. The mCAT method showed 100% categorical agreement with CAT and 99.3% concordance with BMD (304/306 isolates). Among all isolates, two very major errors were observed only in Enterobacter cloacae, with none detected in Escherichia coli or Klebsiella pneumoniae. The mCAT reduced procedural steps and resource use without compromising test performance, saving up to 30 minutes daily spent preparing additional saline tubes and 1:10 dilutions in a high-throughput laboratory. Conclusion: The mCAT method offers a reliable, simplified, and cost-effective alternative to standard colistin susceptibility testing for Enterobacterales. It holds particular promise for microbiology laboratories in low- and middle-income countries, where routine BMD testing is limited, and sample volumes are high. Keywords: Colistin susceptibility testing, colistin agar test, modified CAT (mCAT), Enterobacterales, antimicrobial resistance
- 30 March 2026
- Published by Doc Design and Informatics Co. Ltd. in Infectious Diseases and Clinical Microbiology
- Vol. 8 (2) , 139-143
Open AccessModification of CLSI Recommended Colistin Agar Test for Enterobacterales to Handle Large Sample Load in a High-Throughput Laboratory
Objective: Accurate colistin susceptibility testing is critical but remains challenging, especially in resource-limited settings with a high workload. Broth microdilution (BMD) is the reference standard; however, it is time- and resource-intensive. The colistin agar test (CAT) offers a viable alternative; however, the additional step of preparing a 1:10 dilution can limit routine workflow. This study aimed to evaluate a simple modification of the CAT for Enterobacterales. Materials and Methods: Enterobacterales isolates were tested using BMD, the standard CAT, and modified CAT (mCAT). The mCAT uses an undiluted 0.5 McFarland inoculum with a reduced inoculum volume (1 µL), instead of the Clinical and Laboratory Standards Institute (CLSI)-recommended 10 µL of a one-tenth-diluted suspension, simplifying the protocol while maintaining an equivalent bacterial inoculum load. Results: A total of 306 Enterobacterales isolates (102 colistin-resistant and 204 intermediate) were evaluated. The mCAT method showed 100% categorical agreement with CAT and 99.3% concordance with BMD (304/306 isolates). Among all isolates, two very major errors were observed only in Enterobacter cloacae, with none detected in Escherichia coli or Klebsiella pneumoniae. The mCAT reduced procedural steps and resource use without compromising test performance, saving up to 30 minutes daily spent preparing additional saline tubes and 1:10 dilutions in a high-throughput laboratory. Conclusion: The mCAT method offers a reliable, simplified, and cost-effective alternative to standard colistin susceptibility testing for Enterobacterales. It holds particular promise for microbiology laboratories in low- and middle-income countries, where routine BMD testing is limited, and sample volumes are high. Keywords: Colistin susceptibility testing, colistin agar test, modified CAT (mCAT), Enterobacterales, antimicrobial resistance
- 31 January 2026
- Published by Elsevier in Experimental Parasitology
- Vol. 282, 109110
Prevalence of intestinal parasites in a tertiary care hospital and utility of AI-assisted fecal analyzer for their detection
- 31 January 2026
- Published by Elsevier in Experimental Parasitology
- Vol. 282, 109110
Prevalence of intestinal parasites in a tertiary care hospital and utility of AI-assisted fecal analyzer for their detection
- 4 April 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (9) , 671-675
Utility of Fecal Biomarkers to Predict Invasive Nature of Acute Infectious Diarrhea in Indian Children
Objective To determine role of fecal calprotectin (FC) and fecal lactoferrin (FL) in diagnosis of invasive diarrhea. Methods Stool samples from 75 children (≤ 12 years) with acute diarrhea were analysed using wet mount microscopy, culture, multiplex polymerase chain reaction, rapid tests for Rotavirus/ Adenovirus and quantitative ELISA for FC and FL. Results The mean (SD) FC levels (μg/g) [774 (626.59) vs. 213 (251.48), P < 0.001] and FL levels (μg/g) [7.95 (4.72) vs. 4.22 (3.91), P = 0.004] were significantly higher in children with invasive diarrhea (n = 38) compared to those with non-invasive diarrhea (n = 37). Cut-off values of FC > 243 μg/g (sensitivity 81.57%, specificity 67.56%, AUC 0.813) and for FL > 6.02 μg/g (sensitivity 71.05%, specificity 81.08%, AUC 0.732) have diagnostic potential. Conclusions FC and FL can aid diagnosis of acute invasive diarrhea.
- 4 April 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (9) , 671-675
Utility of Fecal Biomarkers to Predict Invasive Nature of Acute Infectious Diarrhea in Indian Children
Objective To determine role of fecal calprotectin (FC) and fecal lactoferrin (FL) in diagnosis of invasive diarrhea. Methods Stool samples from 75 children (≤ 12 years) with acute diarrhea were analysed using wet mount microscopy, culture, multiplex polymerase chain reaction, rapid tests for Rotavirus/ Adenovirus and quantitative ELISA for FC and FL. Results The mean (SD) FC levels (μg/g) [774 (626.59) vs. 213 (251.48), P < 0.001] and FL levels (μg/g) [7.95 (4.72) vs. 4.22 (3.91), P = 0.004] were significantly higher in children with invasive diarrhea (n = 38) compared to those with non-invasive diarrhea (n = 37). Cut-off values of FC > 243 μg/g (sensitivity 81.57%, specificity 67.56%, AUC 0.813) and for FL > 6.02 μg/g (sensitivity 71.05%, specificity 81.08%, AUC 0.732) have diagnostic potential. Conclusions FC and FL can aid diagnosis of acute invasive diarrhea.
- Open Access
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Ophthalmology
- Vol. 16 (2) , 94-99
Chronic Post-operative Endophthalmitis caused by Acinetobacter Baumannii: A Case Presentation
Introduction: Endophthalmitis caused by Acinetobacter baumannii (A. baumannii) has been rarely reported in literature. Case: A case of chronic post-operative endophthalmitis (CPE) from A. baumannii is reported here. A 50-year-old hypertensive male did not gain good vision following implantation of a three-piece +20.0 diopter intraocular lens (IOL) in his left eye (LE). Five months later, he was referred to retina services with gross diminution of vision and whiteness of the cornea. An ultrasound B scan was done to assess the posterior segment. The pars plana vitrectomy could not be done due to corneal opacity. The specimen obtained from the anterior segment wash was sent for culture and sensitivity. Observation: The left eye (LE) had perception of light with an inaccurate projection of rays in all quadrants. On slit lamp examination, the cornea showed oedema, Descemet’s membrane folds, peripheral vascularisation and a blood-stained endothelium. The intraocular pressure (IOP), keratometry and axial length were 12 mmHg, 41.5 x 45.75 and 22.25 mm respectively. The ultrasound B scan showed a well-defined vitreous opacity with moderate to high echoes in the posterior segment pointing towards vitritis with IOL and cortical lens matter drop. There was choroidal detachment (CD) in one quadrant. The anterior segment specimen grew colonies of A. baumannii sensitive to co-trimoxazole, minocycline, and levofloxacin. Oral levofloxacin 750 mg once a day for ten days was prescribed, but his ocular condition did not improve. The IOP reduced to 8 mmHg, and a repeat ultrasound showed serous CD in two quadrants. Even with systemic steroids, inflammation did not resolve fully and LE had only perception of light one month later. Conclusion: A. baumannii should be kept as a differential diagnosis in cases of CPE. As it is multidrug resistant and therapeutic options are limited, endophthalmitis caused by this bacterium has a poor prognosis.
- 31 December 2024
- Published by Nepal Journals Online (JOL) in Nepalese Journal of Ophthalmology
- Vol. 16 (2) , 94-99
Open AccessChronic Post-operative Endophthalmitis caused by Acinetobacter Baumannii: A Case Presentation
Introduction: Endophthalmitis caused by Acinetobacter baumannii (A. baumannii) has been rarely reported in literature. Case: A case of chronic post-operative endophthalmitis (CPE) from A. baumannii is reported here. A 50-year-old hypertensive male did not gain good vision following implantation of a three-piece +20.0 diopter intraocular lens (IOL) in his left eye (LE). Five months later, he was referred to retina services with gross diminution of vision and whiteness of the cornea. An ultrasound B scan was done to assess the posterior segment. The pars plana vitrectomy could not be done due to corneal opacity. The specimen obtained from the anterior segment wash was sent for culture and sensitivity. Observation: The left eye (LE) had perception of light with an inaccurate projection of rays in all quadrants. On slit lamp examination, the cornea showed oedema, Descemet’s membrane folds, peripheral vascularisation and a blood-stained endothelium. The intraocular pressure (IOP), keratometry and axial length were 12 mmHg, 41.5 x 45.75 and 22.25 mm respectively. The ultrasound B scan showed a well-defined vitreous opacity with moderate to high echoes in the posterior segment pointing towards vitritis with IOL and cortical lens matter drop. There was choroidal detachment (CD) in one quadrant. The anterior segment specimen grew colonies of A. baumannii sensitive to co-trimoxazole, minocycline, and levofloxacin. Oral levofloxacin 750 mg once a day for ten days was prescribed, but his ocular condition did not improve. The IOP reduced to 8 mmHg, and a repeat ultrasound showed serous CD in two quadrants. Even with systemic steroids, inflammation did not resolve fully and LE had only perception of light one month later. Conclusion: A. baumannii should be kept as a differential diagnosis in cases of CPE. As it is multidrug resistant and therapeutic options are limited, endophthalmitis caused by this bacterium has a poor prognosis.
- 4 October 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 52, 100739
Utilization of MALDI-TOF MS in the etiological diagnosis of deep-seated anaerobic bacterial infections
- 4 October 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 52, 100739
Utilization of MALDI-TOF MS in the etiological diagnosis of deep-seated anaerobic bacterial infections
- 3 June 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (12) , 1252-1258
In vitro assessment of newer colistin-sparing antimicrobial agents for clinical isolates of carbapenem-resistant organisms
- 3 June 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (12) , 1252-1258
In vitro assessment of newer colistin-sparing antimicrobial agents for clinical isolates of carbapenem-resistant organisms
- 7 May 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 49, 100602
Possible impact of revisions in disc diffusion breakpoints for aminoglycosides and piperacillin/tazobactam in the 33rd edition of CLSI M100 document on clinical reporting and use in Indian settings with low susceptibility
- 7 May 2024
- Published by Elsevier in Indian Journal of Medical Microbiology
- Vol. 49, 100602
Possible impact of revisions in disc diffusion breakpoints for aminoglycosides and piperacillin/tazobactam in the 33rd edition of CLSI M100 document on clinical reporting and use in Indian settings with low susceptibility
- Open Access
- 1 January 2023
- Published by Medknow in MAMC Journal of Medical Sciences
- Vol. 9 (1) , 35-43
Tracking Annual Antimicrobial Resistance at a Tertiary Care Hospital amidst Raging COVID-19 Pandemic
Background: Timely preparation and presentation of the annual cumulative antibiogram play an important role in the dissemination of an updated susceptibility pattern to clinicians and thus aid in the appropriate choice of antimicrobials for empirical therapy while minimizing adverse effects and resistance. The study aimed to present and analyze the annual AMR data that may be helpful in designing antibiotic policy.Methods: All clinical specimens routinely submitted to the Department of Microbiology from January to December 2021 for bacteriological culture and antimicrobial susceptibility testing (AST) were included. AST was performed for pathogenic isolates by disc diffusion/agar dilution/broth microdilution methods/VITEK® 2 compact system. All data were entered and analyzed using WHONET 2020 software.Results: A total of 46,629 routine specimens were processed, yielding 5792 non-repeat bacterial isolates. Relatively fewer specimens were received during the first few months when the hospital catered exclusively to COVID-19 patients. The most common bacterial isolates wereEscherichiacoli(30%),Staphylococcus aureus(21%),Klebsiella sp. (18%),Pseudomonas sp. (10%),Acinetobacter sp.(8%) andEnterococcus sp.(5%). Analysis showed low susceptibility to 3rd generation cephalosporins, fluroquinolones, and cotrimoxazole among Gram negative bacteria. Less than 50% Acinetobacter sp. were carbapenem susceptible. We report high rate of methicillin resistance inS. aureus(74%). Overall susceptibility was much lower in specimens from ICU followed by in-patients and out-patients.Conclusion: Antimicrobial resistance is rapidly assuming the proportions of a pandemic, with several authors calling it “invisible” pandemic. As is evident from the present study, low susceptibilities to all but a few last-resort drugs are leaving few choices for treatment. This mandates effective preparation, distribution, and presentation of annual antibiograms, which will help in formulating hospital antibiotic policy.
- 1 January 2023
- Published by Medknow in MAMC Journal of Medical Sciences
- Vol. 9 (1) , 35-43
Open AccessTracking Annual Antimicrobial Resistance at a Tertiary Care Hospital amidst Raging COVID-19 Pandemic
Background: Timely preparation and presentation of the annual cumulative antibiogram play an important role in the dissemination of an updated susceptibility pattern to clinicians and thus aid in the appropriate choice of antimicrobials for empirical therapy while minimizing adverse effects and resistance. The study aimed to present and analyze the annual AMR data that may be helpful in designing antibiotic policy.Methods: All clinical specimens routinely submitted to the Department of Microbiology from January to December 2021 for bacteriological culture and antimicrobial susceptibility testing (AST) were included. AST was performed for pathogenic isolates by disc diffusion/agar dilution/broth microdilution methods/VITEK® 2 compact system. All data were entered and analyzed using WHONET 2020 software.Results: A total of 46,629 routine specimens were processed, yielding 5792 non-repeat bacterial isolates. Relatively fewer specimens were received during the first few months when the hospital catered exclusively to COVID-19 patients. The most common bacterial isolates wereEscherichiacoli(30%),Staphylococcus aureus(21%),Klebsiella sp. (18%),Pseudomonas sp. (10%),Acinetobacter sp.(8%) andEnterococcus sp.(5%). Analysis showed low susceptibility to 3rd generation cephalosporins, fluroquinolones, and cotrimoxazole among Gram negative bacteria. Less than 50% Acinetobacter sp. were carbapenem susceptible. We report high rate of methicillin resistance inS. aureus(74%). Overall susceptibility was much lower in specimens from ICU followed by in-patients and out-patients.Conclusion: Antimicrobial resistance is rapidly assuming the proportions of a pandemic, with several authors calling it “invisible” pandemic. As is evident from the present study, low susceptibilities to all but a few last-resort drugs are leaving few choices for treatment. This mandates effective preparation, distribution, and presentation of annual antibiograms, which will help in formulating hospital antibiotic policy.
- Open Access
- 1 December 2016
- Vol. 16 (1) , 11-16
True Prevalence of Shigellosis in Indian Children with Acute Gastroenteritis: Have We Been Missing the Diagnosis?
Background: Shigella is responsible for high morbidity and mortality among children, yet its true prevalence remains inconclusive. The aim of this study was to determine the actual prevalence of Shigella infection in childhood diarrhea and dysentery cases and assess the applicability of ipaH gene PCR in Indian settings. Methods: This study was conducted at Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, India during 2011-12. A total of 385 children (207 with diarrhea, 118 with dysentery, and 60 matched controls) were enrolled. Stool samples were cultured, and the suspected colonies were analyzed using biochemical reactions and serotyping. Antimicrobial susceptibility testing was done using disc diffusion method. ipaH-gene PCR was performed directly on stool samples collected from 180 randomly selected patients (60 from each group). Results: Shigella was isolated using conventional culture methods in 8.2% (95% CI: 5.1%, 12.8%), 33.1% (95% CI: 25.2%, 42.0%), and 0% in the diarrhea, dysentery and control cases, respectively. High resistance was seen towards co-trimoxazole, nalidixic acid, fluoroquinolones, doxycycline and several beta-lactams drugs. Actual prevalence of shigellosis was determined using ipaH gene PCR to be 18.3% (95% CI: 10.4% -30.1%) diarrhea cases and 56.7% (95% CI: 44.1, 68.4%) dysentery cases. One (1.7%, 95% CI: 0.01%, 9.7%) control specimen also yielded positive result in PCR. Conclusions: Correct diagnosis of shigellosis is essential to start antimicrobial therapy in selected cases. The prevalence of Shigella / EIEC infection in children is much higher than previously estimated. Despite its high costs and other limitations, we recommend the use of ipaH-gene PCR as a routine tool in the management of childhood acute gastroenteritis cases.
- 1 December 2016
- Vol. 16 (1) , 11-16
Open AccessTrue Prevalence of Shigellosis in Indian Children with Acute Gastroenteritis: Have We Been Missing the Diagnosis?
Background: Shigella is responsible for high morbidity and mortality among children, yet its true prevalence remains inconclusive. The aim of this study was to determine the actual prevalence of Shigella infection in childhood diarrhea and dysentery cases and assess the applicability of ipaH gene PCR in Indian settings. Methods: This study was conducted at Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi, India during 2011-12. A total of 385 children (207 with diarrhea, 118 with dysentery, and 60 matched controls) were enrolled. Stool samples were cultured, and the suspected colonies were analyzed using biochemical reactions and serotyping. Antimicrobial susceptibility testing was done using disc diffusion method. ipaH-gene PCR was performed directly on stool samples collected from 180 randomly selected patients (60 from each group). Results: Shigella was isolated using conventional culture methods in 8.2% (95% CI: 5.1%, 12.8%), 33.1% (95% CI: 25.2%, 42.0%), and 0% in the diarrhea, dysentery and control cases, respectively. High resistance was seen towards co-trimoxazole, nalidixic acid, fluoroquinolones, doxycycline and several beta-lactams drugs. Actual prevalence of shigellosis was determined using ipaH gene PCR to be 18.3% (95% CI: 10.4% -30.1%) diarrhea cases and 56.7% (95% CI: 44.1, 68.4%) dysentery cases. One (1.7%, 95% CI: 0.01%, 9.7%) control specimen also yielded positive result in PCR. Conclusions: Correct diagnosis of shigellosis is essential to start antimicrobial therapy in selected cases. The prevalence of Shigella / EIEC infection in children is much higher than previously estimated. Despite its high costs and other limitations, we recommend the use of ipaH-gene PCR as a routine tool in the management of childhood acute gastroenteritis cases.